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about this report
As access to antiretroviral therapy expands in the developing world, millions of people will be drawn into
health care settings, providing critical new opportunities to simultaneously expand access to hiv prevention.
This report by the Global hiv Prevention Working Group makes detailed recommendations on how to 
effectively integrate hiv prevention into expanding hiv treatment programs. The report also provides 
recommendations on new approaches to hiv prevention that will be required as treatment access expands —
including programs that take into account the different needs of people who are hiv-positive and hiv-negative.
the global hiv prevention working group
The Global hiv Prevention Working Group is a panel of nearly 50 leading public health experts, clinicians, 
biomedical and behavioral researchers, and people affected by hiv/aids, convened by the Bill & Melinda Gates 
Foundation and the Henry J. Kaiser Family Foundation. The Working Group seeks to inform global 
policy-making, program planning, and donor decisions on hiv prevention, and to advocate for a comprehensive
response to hiv/aids that integrates prevention and care. In July 2002, the Working Group issued its first report,
Global Mobilization for hiv Prevention: A Blueprint for Action. In May 2003 it released Access to hiv Prevention: 
Closing the Gap. Both are available at www.gatesfoundation.org and www.kaisernetwork.org.
ccess to hiv treatment and care in developing
countries is at last becoming a global priority.
Governments, international agencies, drug
manufacturers, and private organizations are
mobilizing to substantially increase access to life-
prolonging antiretroviral therapy (art).
Greater availability of hiv treatment* for the 40
million people currently infected with hiv is a humani-
tarian imperative that could prolong
the lives of millions, restore
economic productivity, and stabilize
societies in some of the world’s
hardest-hit regions.
But long-term success against hiv/aids requires
simultaneous expansion of both art and prevention.
Unless the incidence of hiv is sharply reduced, hiv treat-
ment will not be able to keep pace with all those who will
need therapy. For example, while the who/unaids 3 by 5
Initiative establishes the goal of having 3 million people
on art by 2005, 5 million new infections occur every year.
New Opportunities
The world has a unique opportunity, as art programs 
are launched and expanded, to simultaneously bolster
prevention efforts. 
Increased availability of hiv treatment is likely to 
result in increased hiv testing rates, reduced stigma, and
possibly reduced infectivity for those on art. But more
widespread access to hiv treatment could also bring
millions of people into health care settings, providing 
new opportunities for health care workers to deliver and
reinforce hiv prevention messages and interventions.
Pilot programs in developing countries are demonstrating
that such an integrated approach is feasible and can
substantially increase condom use and hiv testing rates.
New Challenges
Greater art access will also present new challenges for
hiv prevention programs. Experience in industrialized
countries suggests that hiv treatment access can alter
people’s perception of the risk associated with hiv, and
can lead to increased risk behavior. In addition, because
art can significantly increase the longevity and health of
people living with hiv, the number of opportunities for
hiv transmission to occur could increase. 
As testing rates increase and more people learn 
their hiv status, there is a unique opportunity to adapt
prevention strategies to meet the differing needs of hiv-
positive and hiv-negative people.
While not all prevention services
will be targeted this way, such a
targeted prevention approach is
now possible:
t Prevention for hiv-Positive People. Although most
people diagnosed with hiv take steps to avoid exposing
others to the virus, some have difficulty maintaining
safer behavior, making “prevention for positives” a critical
strategy in reducing the number of new hiv infections.1
t Prevention for hiv-Negative and Untested People.
Prevention strategies for hiv-negative and untested
people must be adapted to ensure that risk behavior
does not increase in the context of art access. 
Ultimate Goal: Widespread Access to 
hiv Prevention and Treatment
Globally, fewer than one in five people at high risk of infec-
tion have access to proven hiv prevention interventions2—
voluntary hiv counseling and testing, condom promotion
campaigns, treatment for sexually transmitted diseases
(stds), drugs and strategies to prevent mother-to-child
transmission of hiv, and harm reduction programs for
injecting drug users, among others. In the case of anti-
retroviral therapy, access in developing countries is even
lower — only 7% of people who need art in low- and
middle-income countries currently receive it.
If the world fails to act now to expand access to hiv
prevention during this critical time of growing art access,
1
* Throughout this report the term “hiv treatment” is used to refer to antiretroviral
therapy. The Working Group recognizes that there is a spectrum of treatment
needs for people living with hiv, including treatment for tb, opportunistic 
infections and other conditions associated with hiv infection.  
EXECUTIVE SUMMARY
The world has a unique opportunity
to simultaneously expand both 
treatment and prevention.
we could repeat the mistakes of the industrialized world,
where hiv prevention was not sufficiently prioritized as
hiv treatment was expanded, leading to an increase in
risk behavior and infection rates. 
However, if the world mobilizes to simultaneously and
aggressively expand both hiv prevention and treatment, we
could achieve a truly comprehensive approach to fighting
aids that could contain and ultimately reverse the epidemic.
summary of 
recommendations
The Working Group recommends a four-point plan of action:
1. Integrate hiv Prevention and Treatment
t Expansion of Access to hiv Testing. Because hiv
counseling and testing is a critical entry point for both
prevention and art services, testing programs should
be significantly expanded and aggressively promoted.
As art is introduced, testing should remain voluntary
and confidential. Where art access exists, hiv testing
and counseling should be universally offered in all
health care settings — including std and tb clinics,
family planning and reproductive health clinics,
prenatal and prevention of mother-to-child transmis-
sion (pmtct) settings, and mobile health programs in
rural areas — provided individuals have the ability to
opt out of testing. 
t hiv Prevention in Health Care Settings. All health care
settings, including hiv treatment sites, should deliver
hiv prevention services. Doctors, nurses, and non-
clinical staff in health care settings — including art
sites, tb and std clinics, family planning and reproduc-
tive health clinics, harm reduction programs for 
injection drug users, maternal-child health clinics, and
pmtct programs — should be trained to provide hiv
prevention counseling, access to condoms and other
prevention tools, and screening for sexually transmitted
diseases. Risk reduction strategies should also be 
integrated into initiatives that promote art adherence.
Prevention and treatment services should be tailored to
meet the specific needs of women, recognizing the
multiple social, legal, and economic disadvantages
they confront. Special efforts will similarly be needed 
to make integrated prevention and treatment a reality
for young people, who often do not enter the care
system until they are adults.
t art Promotion in Prevention Services. Prevention
outreach programs should promote hiv testing,
educate communities about hiv treatments, and 
facilitate linkages to care. In some circumstances, such
as harm reduction programs, prevention programs
may actually serve as ideal venues for the delivery of
art and other hiv/aids treatment. 
t Donor Priorities. Donors and national programs should
prioritize integration of prevention in art settings. The
Global Fund and the World Bank Multicountry aids
Program should prioritize funding for proposals that
include delivery of prevention services in art settings.
who should ensure that 3 by 5 Initiative staff receive
training on hiv prevention as part of training and 
technical assistance activities. Bilateral and multilateral
donors, such as the U.S. government and the World
Bank, should ensure that all programs integrate compre-
hensive, science-based hiv prevention in the delivery of
art, and should require programs to report on progress
toward prevention-treatment integration. Individual
countries should revise their aids strategic plans to
prioritize integration of hiv prevention in treatment
settings. unaids and who should emphasize the impor-
tance of integrating prevention services in art settings
in their technical assistance on Global Fund proposals. 
t Research. Research efforts should be strengthened 
and expanded to identify the most effective strategies
for integrating hiv prevention and treatment. who
and unaids should develop mechanisms to rapidly
disseminate research findings to the field.
2. Deliver Prevention for hiv-Positive People
t “Prevention for Positives.” New prevention programs
tailored to the needs of people living with hiv should
be developed and implemented. Programs should
include counseling regarding personal disclosure of
hiv status, information on the ability of individuals 
to transmit hiv even while on art, and promotion of
safer behavior. Research should be quickly undertaken
to identify optimal messages and strategies for
reaching hiv-positive people.
t Involving People Living with hiv. Donors and govern-
ments should provide financial support to organiza-
tions of people living with hiv. Such organizations
should be involved in the planning, development,
delivery, and evaluation of hiv prevention services for
people living with hiv.
2
3t Fighting Stigma. Efforts to combat hiv-related stigma
and discrimination must be strengthened and
sustained. Enforceable laws must be in place to protect
people with hiv from discrimination. Community-based
initiatives that empower people living with hiv will help
increase rates of voluntary testing, clinic attendance, and
participation in hiv prevention efforts.
3. Adapt Prevention for hiv-Negative People
t New Messages. Prevention strategies for hiv-negative
and untested people should be revised to emphasize the
continuing importance of risk reduction as hiv treat-
ment access expands and to address the limitations of
art. Evaluation of existing programs should be under-
taken to provide information about successful strategies.
t Monitoring Behavioral Impact of art. Behavioral
surveillance and sentinel surveillance must be 
significantly expanded to monitor the effect of art
access on risk behavior and trends in hiv prevalence.
4. Fund a Comprehensive Response 
t Simultaneous Scale-Up of Prevention and Treatment.
To expand access to the full range of proven hiv
prevention and treatment interventions, hiv/aids
spending from all sources should increase from $4.7
billion in 2003 to $10.5 billion in 2005 and to $15
billion in 2007, as recommended by unaids.
t Addressing Barriers to Scale-Up. Funding initiatives
for hiv prevention and treatment must include both
short- and long-term strategies to build sustainable
capacity in countries to deliver essential services —
including health care infrastructure and training for
health care personnel.
t Research into New Prevention Technologies. Annual
funding for hiv vaccine research should double from
approximately $520 million to $570 million today to at
least $1 billion in 2007. Annual funding for microbicide
research should increase from less than $150 million
today to $300 million in 2007. In addition, funding
should substantially increase for research into other
prevention technologies, such as female condoms,
diaphragms, circumcision, treatment of viral stds, 
and oral chemoprophylaxis. Opportunities for people
to participate in clinical trials of new prevention tech-
nologies should be linked with hiv testing, prevention,
and art services. 
These recommendations are intended to provide guidance on
one critical aspect of the global response to aids — the need 
to integrate hiv prevention into health care settings, and
adapt hiv prevention strategies in the era of increased access
to hiv treatment. In addition to the recommendations identi-
fied here, it will also be essential to scale up access to the full
array of proven prevention interventions in all settings. 
In earlier reports, the Working Group has identified the 
key elements of an effective effort to prevent hiv transmis-
sion. Even if prevention is more fully integrated into
expanded art programs, many prevention services 
will need to be offered outside medical settings. This is
especially the case for young people, who have much lower
rates of hiv infection than adults and are therefore not as
likely to visit hiv treatment sites.
Effective prevention involves a series of strategies that
achieve maximum impact when pursued in combination.
These elements include:
t Behavior change programs to promote condom use,
reduction in the number of partners, mutual monogamy,
abstinence, and delayed initiation of sexual activity
t Prevention and treatment of sexually transmitted diseases
t hiv counseling and testing
t Harm reduction programs for injecting drug users
t Prevention of mother-to-child transmission
t Blood safety practices
t Infection control in health care settings
t Policy reforms to reduce the vulnerability of women and
girls, and ensure the legality and availability of proven hiv
prevention strategies such as condoms and clean syringes
t Prevention programs specifically designed for people
living with hiv
In addition to expanding access to existing interventions,
the rapid development and deployment of new tools —
such as vaccines and microbicides, once developed — will
be a crucial part of the comprehensive response to the
epidemic. 
bringing comprehensive hiv prevention 
to scale
he world has entered a new stage in the fight
against hiv/aids. Fueled by a determination to
improve the health and well-being of nations where
95% of the world’s hiv-infected people live, the
global community is beginning a major effort to expand
access to anti-retroviral therapies (art) and other hiv-
related health services. 
Since 2001, when 189 member
states of the United Nations
endorsed worldwide hiv treat-
ment access in the Declaration of
Commitment on hiv/aids, efforts
to deliver art in developing coun-
tries have accelerated.3
who and unaids have established a global target of
having 3 million people on art by 2005. As of early
2004, the Global Fund had approved grants to support
the provision of art to 700,000 people. The President’s
Emergency Plan for aids Relief (pepfar) initiative of the
U.S. government plans to deliver art to 2 million people
by 2007 in 14 high-prevalence countries in sub-Saharan
Africa and the Caribbean. The World Bank also has
announced plans to increase its financial assistance for
art programs in eligible countries, with particular focus
on support for the infrastructure that will be required to
initiate and sustain treatment programs. Countries in
diverse regions are also examining national policies and
funding allocations to facilitate the delivery of art
through the public sector.
These initiatives must overcome substantial obstacles
in resource-limited settings, including the need to recruit
and train tens of thousands of health care workers. By
late 2003, only 400,000 people in low- and middle-
income countries were receiving art, reflecting treat-
ment coverage of only 7%.4 Despite the many challenges
confronting the global community, however, it is clear
that the response to hiv/aids is entering a stage of
expanded access to art. 
In addition to the therapeutic benefits that will flow to
millions of hiv-infected individuals, enhanced art access
will offer important new opportunities to strengthen and
expand hiv prevention efforts. Increased availability of hiv
treatment is likely to result in increased hiv testing rates,
reduced stigma, and possibly reduced infectivity for those
on art. But more widespread
access to art also offers critical
new opportunities for hiv preven-
tion efforts: 
t Integration of Prevention and
Treatment. As access expands,
art will be delivered in health care venues where hiv
prevention services can be offered.
t Prevention for hiv-Positive People. As more people
learn their hiv status in the context of expanded art
access, prevention programs should develop and direct
services to people living with hiv.
t New Strategies for hiv-Negative or Untested Individuals.
Prevention programs will need to anticipate and seek to
minimize potential increases in risk behavior associated
with increased access to art by updating prevention
messages and strategies to ensure their relevance and
effectiveness. 
The potential health dividends from seizing these new
opportunities are enormous. If rapid expansion of art is
combined with a dramatically scaled-up prevention effort,
the world could substantially reduce the severity of the
global epidemic. In fact, a 2002 study led by unaids and
who reported that existing hiv prevention strategies, if
substantially expanded, could avert 29 million of the 45
million new infections projected to occur between 2002
and 2010.5
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introduction
Rapid scale-up of hiv treatment 
and prevention could improve the 
lives of millions, avert countless new
infections, and ultimately contain 
the global aids epidemic.
5integrating 
hiv prevention in 
health care settings
art can enhance hiv prevention by attracting millions of
individuals into a wide range of health care settings where
prevention services can be offered. Expanded hiv treat-
ment availability will also provide greater incentives for hiv
testing, and testing settings will serve as critical entry
points for both prevention and hiv treatment services.
Increasing Knowledge 
of hiv Status 
Experts estimate that close to 
90% of people living with hiv in
developing countries are unaware of
their infection.6 Because inadequate
knowledge of hiv status impedes
both prevention and hiv treatment
efforts, the percentage of people in developing countries
who know their hiv status must significantly increase.
Numerous factors currently impede widespread knowledge
of hiv status, including the perception that knowledge of
serostatus is not useful where hiv treatment is unavailable.
However, studies demonstrate that knowledge of hiv status
has an independent hiv prevention benefit, leading people
to reduce their risk behavior, even when hiv treatment is
not available.7 art availability will provide much greater
incentive to increase knowledge of hiv status. 
t Limited Access to vct Sites. Historically, the primary
means to learn one’s hiv status in developing countries
is through stand-alone voluntary counseling and testing
(vct) sites. At present, only 12% of individuals who need
vct have meaningful access to testing services, under-
scoring the importance of increased funding for vct.8
t Universal Offer of Voluntary Testing in Health Care
Settings Where art is Available. While stand-alone 
vct sites have long provided an important means of
promoting knowledge of hiv
status, exclusive reliance on these
venues is unlikely to generate the
levels of testing and counseling
needed to achieve prevention and
hiv treatment goals.9 vct depends 
on the individual’s own volition in
coming forward to be tested. 
In areas where art has been
introduced, providers should always offer testing in a
broad range of health care settings, including hospi-
tals, std and tb clinics, family planning and reproduc-
tive health service settings, prenatal care settings, and
mobile health programs in rural areas. Patients should
be given the opportunity to opt not be tested, and confi-
dentiality must in all cases be maintained. Programs
should make maximum use of rapid testing technolo-
gies to increase knowledge of hiv status,10 and donors
should prioritize training in use of such technologies.
Only 12 percent of people who need
voluntary hiv counseling and testing
have access to it. hiv testing services
should be offered in a wide range 
of health care settings — 
from hospitals to tb clinics to mobile
health centers in rural areas.
It is estimated that 90% of people with hiv in the devel-
oping world are unaware of their infection. Expanding
opportunities for voluntary hiv testing will be critical to
expanding access to both prevention and art services, 
yet only 12% of people who need access to testing and
counseling services have it. As art programs expand, it 
is essential that testing opportunities increase:
t Where art is available:
• hiv testing should be universally offered in a broad
range of health care settings, including hospitals, std
and tb clinics, family planning and reproductive health
service settings, prenatal care settings, and mobile
health programs in rural areas. 
• Patients should be given the opportunity to opt not 
be tested, and confidentiality must in all cases be 
maintained. 
• If a patient presents in a health care setting with
possible symptoms of hiv infection, the patient should
be informed that an hiv test will be performed for 
diagnostic purposes unless he or she expressly declines. 
t All blood donors should be advised that their blood will
be tested confidentially for hiv, and hiv-infected blood
donations should be removed from the blood supply.
Donors who test positive for hiv should be notified of 
their hiv status and linked to appropriate care and art
programs. 
t Programs should make maximum use of rapid testing
technologies to increase knowledge of hiv status, 
and donors should prioritize training in use of such 
technologies.
hiv testing: expanding opportunities to
deliver prevention and hiv treatment
6Treatment and prevention are essential partners in the
fight against aids. In the absence of hiv treatment,
prevention programs lack incentives for people to know
their hiv status. Without effective prevention to reduce
the number of new infections, art initiatives will not be
able to keep pace with the spread of the disease.
Potential Prevention Benefits of art
Greater access to art is likely to benefit hiv prevention
efforts in a variety of ways. 
t Increased Knowledge of hiv Status. Pilot art projects 
in Haiti and South Africa have generated increases in
utilization of voluntary counseling and testing (vct)
services of 300%11 and 1,200%,12 respectively. After
former President Fernando Henrique Cardoso of Brazil
decreed in 1996 that art would be provided through
the country’s public health service, demand for vct
soared; by 2003, 2.3 million people were tested, up
from 1.8 million the year before.13 The encouragement
provided by art programs for hiv testing has been
shown to benefit hiv prevention efforts.14 In a
controlled trial in three developing countries (Kenya,
Tanzania, and Trinidad), individuals receiving vct were
nearly three times more likely to reduce risky sexual
behavior than people who received health information
alone, with hiv-infected individuals being more likely
than uninfected people to take protective measures.15
t Reduced Stigma. Stigma impedes the dissemination of
life-saving hiv prevention information within communities
and discourages key social institutions from becoming
engaged in efforts to curb transmission. Early experience
with art scale-up in developing countries suggests that
art access could potentially have a major positive impact
on public attitudes about aids. After Médecins Sans 
Frontières (msf) began providing art in the Khayelitsha
township outside Cape Town, a survey of nine commuter
sites throughout South Africa found that Khayelitsha 
residents were notably more likely than other South
Africans to express willingness to be tested for hiv, seek
hiv/aids information and counseling, and use condoms.16
Researchers associated with an art project in central Haiti
have also detected a decline in hiv-related stigma.17
t Reduced Infectivity. Although definitive evidence is not
yet available, existing data suggests that broad access to
art, when combined with interventions to promote
adherence to drug regimens, might reduce an indi-
vidual’s risk of transmitting hiv.18 The risk of hiv
transmission is strongly correlated with the infected
person’s plasma viral load.19 In individual patients, 
art typically results in a significant reduction in plasma
viral load.20 Strict adherence to art regimens increases
the likelihood that viral suppression will be sustained.21
Whether this potential individual-level prevention
benefit can be extended to an entire population will
depend on the balance between reduced infectivity and
other epidemiological or behavioral factors, such as the
longer lifespan of people who receive art and possible
shifts in community-level risk behavior.  
The Potential for Increased Risk Behavior to 
Overwhelm the Prevention Benefits of art
Experience in industrialized countries indicates that it is
possible for the prevention benefits of art noted above 
to be overwhelmed by complacency about the threat of
hiv/aids and resulting increases in risk behavior and 
new hiv infections.22
Increases in risk behavior may occur for a variety of
reasons, including a belief by some that hiv is no longer as
serious and the perception that hiv-positive people on art
are no longer infectious. People may also have difficulty
adhering to a lifetime of safer sexual behavior. In addition,
art significantly enhances quality of life and personal sense
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7of well being, enabling many individuals to resume sexual
activity — which may involve risky behavior. While this can
be an important benefit of therapy, it could also increase
opportunities for hiv transmission. 
It is too early to know whether increases in risk
behavior seen in industrialized countries will surface in
developing countries as art is introduced. Past evidence
from Kenya suggests, however, that perceived treatment
advances may have had an impact on levels of risk
behavior in that country.
Since 1985, surveys have detected notable increases 
in condom use among commercial sex workers in Kenya.
Evidence indicates, however, that the upward trajectory 
of condom use was twice interrupted when highly touted 
anti-hiv therapies attracted significant public interest. In
1988–90, when press reports in Africa suggested that the
drug Kemron was a cure for aids, reported condom use
plummeted. Again, in 1993–94, when an agent called Pearl
Omega generated comparable press coverage as a possible
treatment for hiv/aids, reported rates of condom use
sharply declined (see Figure 1).
To ensure that increased risk behavior does not over-
whelm the natural prevention benefits of art, it is vital that
art be coupled with a simultaneous expansion of preven-
tion strategies that have been shown to reduce the risk of
hiv transmission. 
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Figure 3. Using available evidence on the likelihood that art reduces individual infectivity, Sally Blower and colleagues modeled the
epidemic’s future course in settings where art is widely available (50–90% coverage). Where risk behavior declines following widespread
introduction of art, as indicated in the lower-left-hand box in the graph, hiv transmission falls, producing a decline in incidence over
time. If risk behavior increases in the context of expanded art, however, the prevention benefits of art will be overwhelmed, leading to
an increase in the rate of new infections and a continuing expansion of the epidemic.
Potential Impact of Risk Behavior on Future Epidemic 
in India with Expanded Treatment Access
Effect of Risk Behavior on the Future Course of the Epidemic with Expanded art Access
Source: J. Valasco-Hernandez et al., 
Lancet Inf Dis 2002;2:487-93.
Roarv = Average number of new
infections generated by one infected
case when art is widely available
Figure 2. Projections by the World Bank estimate a savings of
more than 25 million discounted life-years in India if condom
use remains stable in the era of expanded treatment access. 
If condom use falls by only 10 percentage points following the
introduction of art, however, the net result over time will 
instead be a loss of more than 18 million life-years through 
2033, underscoring the critical need for prevention and treatment
to be brought to scale simultaneously.
Moreover, if India’s program to expand access to art is
coupled with incentives to states and ngos to improve access to
hiv prevention services like condoms, the World Bank projects
that such a program could, by increasing condom use by 20
percentage points, save 79.2 million discounted life years — 
three times more than without the prevention incentives.
Note: Life-years saved 
are discounted at 10%.
Source: Over et al., hiv/aids Treatment and Prevention in India:
Modeling the Costs and Consequences, World Bank, 2004.
When a patient presents in a health care setting
with possible symptoms of hiv infection, providers
should in the course of counseling inform the indi-
vidual that an hiv test will be performed for diagnostic
purposes unless he or she expressly declines. Blood
donors should be advised that their blood will be tested
confidentially for hiv, and hiv-infected blood dona-
tions should be removed from the blood supply.
t Marketing Knowledge of hiv Status. Streamlining
testing procedures will help increase the number of
people tested, but changes in policies and practices 
are unlikely on their own to lead to substantially 
higher testing rates. The stigma associated with hiv
and with the behaviors that lead to transmission often
discourage individuals from being tested, even when
testing and hiv treatment services are readily available.
To increase knowledge of hiv status, enhanced 
availability of testing services must be supported by
marketing strategies that address attitudinal impedi-
ments to testing. In particular, programs should
actively promote the individual benefits of testing. 
In Canada, a country with one of the world’s most
generous single-payer health care systems, authorities
estimate that up to one-third of Canadians with hiv
are unaware of their hiv status.23 Similarly, in the U.S.,
cdc estimates that at least 25% of people living with hiv
are unaware they are infected.24 In Botswana, where
national authorities have committed to scale up art,
knowledge of hiv status remains at low levels. Even
though hiv prevalence is 38% in the adult population in
Botswana, only 65,000 people had used government
testing facilities by the beginning of 2003.25
A recent study in South Africa compared attitudes
of voluntary testers versus those who had not been
tested. Individuals who avoided testing or failed to
return for test results held significantly more negative
attitudes toward the test than those who knew their
hiv status. Untested individuals were significantly
more likely to exhibit social disapproval of people with
hiv and to believe that hiv infection is shameful.26
Delivering prevention services in art clinical settings
art scale-up could bring millions of individuals into
health care settings, providing new opportunities to
deliver and reinforce risk reduction interventions. 
t hiv Prevention Training for Clinicians. Brief clinician-
t delivered prevention interventions have proven effective
for a variety of health conditions, including smoking,
obesity, alcohol abuse, depression, and physical inac-
tivity.27 A recent clinic-based study found that the
delivery by medical providers of brief hiv prevention
messages that emphasize the dangers of unsafe sex
reduced risk behaviors among hiv-positive patients.28 In
contrast to the more structured counseling protocols for
vct, a brief intervention by a clinician could, for
example, remind the patient of the importance of safer
sex, provide information on clinic-based access to
condoms and counseling, and ask if the patient wishes
to discuss issues related to hiv prevention.
Rapid scale-up will require significant efforts to
train health care workers to deliver art. For example,
who envisions the need to train 100,000 clinical and
community-based personnel to facilitate the scale-up of
art programs. Competency in discussing sexual and
drug use behavior with patients and in delivering brief
hiv prevention interventions should be included in all
art-related training protocols.* Training protocols for
clinicians should also include instruction in proper
infection control, such as handling and disposal of
sharp instruments. 
t hiv Prevention Training for Non-Health Care Profes-
sionals. It may not be feasible to rely solely on clinical
staff to deliver prevention services in medical settings.
Clinical personnel in developing countries are already
overburdened, and the weight of demands will only
grow as the world embarks on an unprecedented
expansion of hiv treatment programs. Indeed, surveys
in industrialized countries also indicate that the pace
of clinical care often makes it difficult for health care
workers to deliver prevention services.29
A more sustainable strategy may be to structure 
clinical episodes to permit trained non-health care
professionals to provide prevention services. For
example, a patient waiting to see a clinician can be
provided with hiv prevention information and referred
to other needed services. Clinics and other health
settings should also offer the option of a one-on-one
meeting with a counselor during clinic visits.
t Integrating hiv Prevention into Adherence Support
Programs. Early art initiatives in developing countries
have incorporated strategies to help patients adhere to
treatment. Adherence support strategies that have been
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* In Uganda, where aggressive plans are underway to extend access to art beyond
the private sector, an alliance of Ugandan and North American physicians and
academic experts is helping the country expand human capacity by training clin-
ical staff in the management of hiv/aids, including art. The training curriculum
in Uganda now includes sessions specifically devoted to hiv prevention and the
delivery of brief hiv prevention messages and counseling in clinical settings. 
9used in developing countries include support groups
and counseling interventions in Khayelitsha, South
Africa, community-based adherence workers (known
as accompagnateurs) in Haiti, and various informa-
tional, counseling, and support services in other loca-
tions. Because adherence support and hiv prevention
services both seek to influence individual behavior,
adherence programs provide an especially efficient
entry point for discussion of hiv prevention.
t Access to Condoms. Male and female condoms should
be readily available in all health care settings, but the
“condom gap” is substantial. For example, current
donor country funding for condoms is sufficient to
provide roughly three condoms per year for every adult
male in sub-Saharan Africa.30 As art attracts many
more people to health care settings, clinics provide an
optimal venue to help close the gap in condom access,
which in sub-Saharan Africa alone is estimated at 1.9
billion condoms annually.31 In addition to increasing
the condom supply, distribution problems often
contribute to condom shortages. As in the case of art,
assuring a continuous supply of high-quality condoms
is an urgent global necessity. Addressing stock supply
issues for arvs could yield important lessons for
condom supplies, as well. 
Delivering hiv Prevention Services in Non-art Sites 
An integrated response to hiv/aids will ensure that
prevention and art services are made available in key
health care and social service sites that might be used by
people with hiv.
t Prenatal Clinics and pmtct Programs. Prenatal care
clinics are essential venues for delivering prevention
services to women, as they are often the only point of
contact women in developing countries have with the
health system.32 Programs that implement measures 
to prevent mother-to-child hiv transmission (pmtct)
also offer an ideal venue for delivery of a broad array 
of hiv prevention services. In many respects, pmtct
programs are in the vanguard of efforts to integrate
prevention and hiv treatment. Recognition of the
importance of art for mothers who test hiv-positive 
in prenatal settings led to the formation in December
2001 of the mtct-Plus initiative. Based at Columbia
University’s Mailman School of Public Health in New
York, mtct-Plus seeks to provide lifelong care and art
to hiv-affected families in developing countries. The
initiative is supporting hiv treatment programs in 12
demonstration sites and providing additional financing
for planning in 13 other sites, with an initial goal of
enrolling 10,000 people. 
t tb and std Clinics. tb and std clinics constitute critical
entry points for hiv treatment and care, as well as for
Figure 4. hiv prevention should be integrated into each step in the health care process — especially in settings frequented by people
who are at higher risk for hiv infection. Each site should offer prevention counseling, voluntary hiv testing, and appropriate prevention
tools, such as condoms. hiv-positive people should be referred to treatment, where prevention counseling specifically designed for
hiv-positive people should be delivered, and hiv-negative people should continue to receive prevention support and education both
within and outside of the health care system.
opportunities for hiv prevention  
in the health care system
Health Care Settings hiv Treatment Settings Other Settings
std treatment clinics art delivery sites Voluntary counseling and testing sites
Reproductive and family Treatment education initiatives plwha support programs
planning clinics
tb clinics Treatment adherence programs
Substance abuse clinics
Prevention of mother-to-child 
transmission centers
Prenatal settings
Although art programs are in their early stages in devel-
oping countries, there are several examples of efforts by
countries to simultaneously scale up prevention and treat-
ment, and some pilot projects are specifically exploring
strategies to integrate hiv prevention in art settings. 
Brazil: Expanded Access to Prevention 
and hiv Treatment
The response to hiv/aids in Brazil predated the emergence
of combination art in the mid-1990s. Early responses to
the epidemic — facilitated by strong community activism
and financial support from the World Bank — included
public aids awareness efforts, initiatives to ensure the
safety of national blood supplies, and provision of azt to
hiv-positive patients through the public sector. Brazil has
also prioritized research on new prevention technologies,
beginning with the initiation of a National aids Vaccine
Task Force in 1992.
Distribution of art through the public sector began 
in 1996 in São Paulo and Rio de Janiero and was then
extended nationwide. Since 1996, more than 141,000
people have received art through the public sector in
Brazil. Nationwide access to art has enabled the country
to avert an estimated 58,000 new aids cases and an esti-
mated 90,000 deaths, reduce hiv-related hospitalizations
seven-fold, and realize net savings of $2.2 billion.33
Brazil’s art program benefited from the national capacity
to manufacture high-quality, lower-cost generic equivalents
of antiretroviral drugs. 
The advent of art in Brazil also produced extraordinary
changes in the public response to the epidemic. In the first
year of the country’s art program, the number of people
entering the hiv/aids care system rose by 30%. aids
activism and public awareness of the epidemic have 
significantly strengthened since art was introduced.34
Brazil has coupled its art program with energetic
prevention efforts, including a major nationwide testing
initiative called “Be Aware” to identify approximately
376,000 people who are estimated to be infected with hiv,
but are unaware of their infection. The result has been 
a simultaneous increase in use of art and voluntary 
counseling and testing (see Figure 5). Between 1994 and
2000, the country also initiated dozens of needle exchange
projects, which resulted in steep declines in hiv incidence
among injection drug users. Between 1996 and 2000, as
the country aggressively promoted condoms, sales of
condoms increased by 57%.35
South Africa: An Integrated Response by the 
Private Sector 
A promising South Africa-based program is in the early
launching stage. South Africa’s national hiv prevention
program for youth — loveLife — supports development 
of hiv service delivery in government clinics around the
country. In partnership with the South
African mining company Anglo American,
loveLife is working to integrate prevention
and hiv treatment programs in communi-
ties where Anglo American has its main
operations. 
Anglo American was an early leader
among large South African employers to
commit to providing art to its workers. 
The partnership with loveLife will extend the
benefits of Anglo’s treatment program to the
families of its employees and communities
in which it operates. This program will
establish comprehensive hiv/aids services,
including art management, in government
clinics in the target sites within the context
of an intensive ongoing hiv education and
prevention effort. 
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early experience with coordinated 
prevention and treatment programs
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South Africa: Incorporating Prevention in 
Treatment Settings 
In the Khayelitsha township near Cape Town, South Africa,
Médecins sans Frontières (msf) provides hiv/aids medical 
services in a primary care setting. The msf project relies on
generic medications and seeks to integrate hiv, tb, and std
treatment services. The program includes standardized
regimens, laboratory monitoring, and patient-centered
adherence support strategies. Prevention programs in the
Khayelitsha project offer group services on risk reduction
counseling and disclosure of hiv status to partners.
The Khayelitsha project provides arvs to more than
400 patients. Median weight gain at six months is 8.8 kg,
and at 12 months there is an 83% survival rate and a 70%
reduction in opportunistic infections. Adherence rates are
as high as those reported in developed countries, and 91%
of patients have undetectable viral loads at six months.
There is early evidence that the Khayelitsha project may
be influencing public attitudes in ways that support hiv
prevention. Surveys of South African commuters at nine
different sites found that residents of Khayelitsha had
greater awareness of hiv, more positive feelings toward
voluntary hiv testing, and higher
rates of condom use. 
msf, working in partnership with
provincial health authorities and the
Nelson Mandela Foundation, has
recently expanded its hiv treatment
activities in South Africa to rural public health clinics sites
in the Eastern Cape Province. South Africa’s national hiv
prevention program for youth, loveLife, is working in the
same clinics in an effort to ensure ongoing integration of
prevention services. 
Haiti: Integrating Prevention and hiv Treatment
Partners in Health has long administered a rural health
program in Haiti that has delivered directly observed tb
therapy. In 1998, the program began extending this model
to hiv/aids, providing combination art free of charge.
The Haiti project relies primarily on community-based
care that is closely monitored by outreach workers known
as accompagnateurs. In addition to observing patients take
their therapy, accompagnateurs provide practical and social
support to individuals enrolled in the program. They receive
extensive training on tb and hiv, including medications and
their side effects, confidentiality, referral systems, and
strategies for promoting adherence. Given the many social
and economic challenges confronted by individuals in rural
Haiti, both clinical and non-clinical staff participate in
addressing non-medical impediments to adherence and
health promotion.
A key feature of the Haiti program is its incorporation
of hiv prevention interventions, many of them led by
people with hiv themselves. Patients are routinely 
counseled to avoid risky behaviors.36
Results of the program have been encouraging. The
Partners in Health program is currently following more
than 3,000 patients living with hiv/aids and providing
arvs (through directly observed therapy) to more than
400 patients. Eighty-six percent of patients on arvs have
suppressed viral loads, all have experienced weight gain
and other improvements in health, and fewer than 10%
have required medication changes due to side effects.
This model is now being expanded in other parts of
central Haiti and in certain urban areas.
Botswana: Simultaneous Scale-Up of Prevention and art
Botswana was the first African country to initiate a compre-
hensive response to the epidemic that includes both access
to art and strengthened hiv prevention efforts. Partnering
with the Bill & Melinda Gates Foundation and The Merck
Company Foundation/Merck Co., Inc., the government of
Botswana introduced art in four clinics in 2002. As of April
2004, the art component of
Botswana’s comprehensive program,
known as masa, was providing art
to approximately 14,000 patients. 
art access is one component 
of a comprehensive plan set forth 
in Botswana’s national hiv/aids strategy. In late 2003,
Botswana decided to routinely offer vct in medical
settings. The country is installing 10,500 condom vending
machines in diverse settings and supporting these with
social marketing campaigns. Having installed video 
equipment in all the country’s schools, Botswana is
training teachers to play a role in delivering hiv prevention
messages to young people. The government is conducting
a series of trainings over three years to enhance the ability
of diverse communities and stakeholders to develop 
and deliver prevention interventions that are tailored to
local needs and circumstances. Botswana is also
enhancing support programs for children orphaned by
aids, providing funding to organizations of people living
with hiv/aids, educating its citizens about hiv/aids and
available treatments, and making an offer of hiv testing
and counseling routine in medical settings.
All materials and standard presentations on hiv/aids,
including those specifically targeted to hiv-positive people,
emphasize the importance of hiv prevention and provide
information on correct and consistent condom use. In 2004,
Botswana will increasingly focus on strategies to enhance
the integration of prevention and treatment components.
The Khayelitsha project in South
Africa has successfully provided 
hiv treatment while increasing
condom use in the community.
enhanced prevention programming for people at
increased risk of acquiring hiv. tb is the leading cause
of death for people with hiv, underscoring the neces-
sity of close linkages between tb and hiv/aids clinical
services.37 Likewise, as untreated stds significantly
increase the risk of hiv transmission, std service
settings are ideally positioned to provide hiv testing
and to deliver hiv prevention interventions.
t Family Planning and Reproductive Health Services.
Family planning and reproductive health services 
function as a key entry point for hiv-infected and at-
risk women, providing voluntary hiv counseling and
testing, std screening and treatment, and information
to permit hiv-positive and hiv-negative women to
make informed reproductive health decisions.38 These
settings serve as potentially critical venues for the
delivery of enhanced hiv prevention services and
linkage to art.
Promoting art in hiv Prevention Settings
Not only is hiv prevention critical to reducing the
number of people who will ever need art and thus
helping to preserve the financial and logistical feasibility
of hiv treatment programs, but prevention programs 
also have a vital role to play in the promotion and delivery
of art.
t hiv Prevention Outreach and Education. Prevention
workers should actively promote knowledge of
serostatus; educate communities about art availability,
benefits, and limitations; and facilitate linkages to care. 
t Harm Reduction Programs. Harm reduction programs
offer an ideal venue for delivery of art and other hiv-
related medical services. This is especially important in
the many countries where idus experience over-
whelming barriers to care. 
Coordinated Planning to Promote an 
Integrated Approach
In developed countries, bureaucratic structures have 
often separated hiv prevention and treatment programs.
In practice, this resulted in prevention programs that
focused on hiv-negative individuals and care settings
that provided few, if any, prevention services for hiv-posi-
tive people. As the expansion of art access in developing
countries gets underway, the global community has an
opportunity to do things differently and ensure
maximum synergy between prevention and treatment. A
potentially ideal vehicle for promoting careful integration
of prevention and hiv treatment at the country level is
the Global Fund, which already mandates that all funding
proposals be developed by Country Coordinating Mecha-
nisms. Similarly, the World Bank Multicountry aids
Program, which has pioneered new ways of channeling
hiv-related funds to affected communities, offers another
important avenue for the integration of prevention and
treatment services. 
hiv prevention for
people living with hiv
Because so few people in developing countries are 
aware of their hiv status, prevention programs have
often relied on general messages that implicitly assume
that all individuals are in the same situation. This
approach has sometimes limited the effectiveness and
sophistication of hiv prevention strategies. 
Every new hiv infection through sexual behavior or
injecting drug use requires the participation of one indi-
vidual who is hiv-positive and one who is hiv-negative.
In addition, hiv-positive people can be reinfected with
another strain of hiv, and emerging evidence suggests
that reinfection may accelerate the progression of hiv
disease.39 To maximize the likelihood of success, preven-
tion strategies should influence the behaviors of each
partner. However, individual needs, perspectives, and risk
reduction challenges can differ substantially depending
on hiv status. As more people become aware of their 
hiv status as art access expands, prevention programs
will need to craft carefully tailored strategies that are 
optimally effective for different audiences. 
Although a positive test result typically prompts 
hiv-positive people to avoid transmitting hiv to others,
evidence in developed countries indicates that a notable
share of people with hiv infection have difficulty imple-
menting and/or sustaining safer behavior.40 Historically,
in both developing and industrialized countries, hiv
prevention strategies have almost exclusively targeted
individuals who are uninfected or untested.41
In recent years, experts have recommended the 
development and implementation of community-based
prevention services that are specifically targeted to people
with hiv/aids.42 The U.S. Centers for Disease Control and
Prevention (cdc), for example, allocated $35 million in
fy2003 to program models that address hiv prevention in
the context of art access. Specifically, cdc is supporting a
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While greater art access will generally afford new opportu-
nities to strengthen hiv prevention, certain key populations
will not necessarily benefit from integrating prevention
programs into health care settings, including those who do
not regularly use health care or experience special barriers
to access. Making the integration of prevention and health
care services meaningful for certain populations will require
additional funding, policy reforms, and outreach.
t Young People. Although young people
account for one-half or more all new hiv
infections, they typically enter hiv/aids care
systems many years after infection, when they
are adults. In addition, young people generally have limited
health care options. Even when youth-oriented hiv-specific
health services are available, hiv stigma often discourages
young people from seeking care.
South Africa’s Adolescent-Friendly Clinic Initiative, a part-
nership between the national loveLife program and the
South African health ministry, offers a potentially useful
strategy for overcoming historic impediments to care for
young people and for integrating hiv prevention into 
art settings. The initiative, supported in large part by
financing from the Global Fund, is establishing compre-
hensive youth-friendly hiv services, including treatment
monitoring, in public clinics throughout the country. To
encourage young people to frequent the clinics, loveLife
maintains outreach, youth activities, and educational
programs in the surrounding communities and clinics.
loveLife-trained peer educators, based in the clinics,
provide clinic attendees with hiv prevention information
and counseling.
t Women. Women represent about 50% of all
people living with hiv, including 58% in sub-
Saharan Africa. Infection rates are especially high
among teenage girls due to numerous factors, including
greater physical susceptibility to infection and the high
prevalence of sex with older men, who are more likely than
younger men to be hiv-infected. The above-noted strate-
gies to increase health service utilization for young people
will help draw young girls into care, where they can receive
both medical and hiv prevention services. 
In addition, programs must acknowledge the multiple
social, legal, and economic disadvantages that women
confront. Health services must address access barriers
faced by many women, including lack of transportation,
lack of child care, and limited options for women-oriented
care.43 hiv treatment and prevention programs should
provide guarantees of privacy and confidentiality, and
counseling, referrals, and follow-up about the risk of aban-
donment or violence after disclosing their hiv status,
including links to safe shelters for women.
The Elizabeth Glaser Pediatric aids Foundation (egpaf)
reports that participation in its pmtct clinics has increased,
due in part to concerted efforts to make clinic attendance
more attractive to women. Where transportation, child care,
and other support services are provided, women often
come to view the clinic as a refuge from the day-to-day pres-
sures associated with caregiving. Several egpaf sites now
participate in the mtct-Plus initiative, which offers hiv-
infected women access to art and primary care. Safer sex
counseling is integrated in all egpaf sites.
t Injecting Drug Users. Worldwide, idus account for
approximately 10% of all hiv infections.44 In many parts
of the world, injecting drug use is driving the epidemic,
with idus representing the largest share of cases.45
Due to longstanding barriers to health care access
experienced by injection drug users,46 bringing prevention
to traditional clinical settings may not suffice to produce
an integrated public health strategy. In the case of idus, it
may be more feasible to bring art to more accessible and
client-centered harm reduction programs that are currently
providing essential hiv prevention services, such as
syringe and needle programs, drug substitution therapy,
and mobile van programs. 
Integration of prevention and treatment in harm 
reduction settings will require substantially greater support
for harm reduction programs. In the Russian Federation,
for example, existing harm reduction services are able to
reach only about 3–5% of those in need.47 In Russia and
several other countries in Central Asia and Eastern Europe,
legal reform is also needed to eliminate harassment of
harm reduction programs and to legalize methadone
maintenance or other drug substitution therapy.48
unique needs of key populations
series of U.S.-based demonstration projects to evaluate and
compare various approaches to “prevention for positives.”49
Prevention programs targeted to hiv-positive people must,
for example, underscore that transmission is still possible, even
when a person is on art. It is critical that research be under-
taken to determine the most effective messages to influence
the risk behavior of hiv-positive people.
art will help many people with hiv recover sexual
desire that had been lost due to
illness. Prevention programs for
people with hiv must acknowl-
edge the natural desire to
engage in sexual activity, and
provide individually tailored support to facilitate safer
sexual choices.50
Organizations of people living with hiv are often
ideally positioned to deliver hiv prevention services. In
Thailand, national efforts to expand access to art have
enlisted hiv-positive patients on therapy to help convince
the public that hiv therapy works. Botswana’s national
aids program provides financial support to organizations
of people with hiv, enabling them to build capacity to
increase understanding of the benefits and limitations of
art, and provide education and counseling on living with
hiv/aids.
hiv prevention for
people who are 
uninfected or
untested
While greater art access will have the
most obvious impact on people living
with hiv, it may also alter the perspec-
tives of people who are uninfected or
untested. As fewer people become ill
and fewer die, the disease may come
to seem less threatening. Individuals
who have taken steps to reduce their
risk due to fear of contracting hiv
may over time relax their guard
against infection.
As art access expands, prevention
programs will need to anticipate such
potential behavioral shifts by helping
people understand both the benefits
and limitations of current therapies. In
particular, common ground must be
found between the need to stress the potential benefits of
art and the prevention imperative of emphasizing that
hiv infection, a preventable and incurable condition,
should be avoided. 
Key to striking a reasonable balance between these
competing interests is the development of meaningful
“treatment literacy” in developing countries.51 Improving
community-based treatment awareness will help people
understand hiv treatment
options, assist in the de-stigma-
tization of the disease, enable
the broader public to make
informed decisions on the 
risks and benefits of relevant behaviors, and help individ-
uals understand that people on art are still infectious.
Botswana’s national art program — entitled masa,
which means “hope” in the local language — couples the
use of hope in its public messages with extensive educa-
tion regarding the benefits and limitations of therapies.
To ensure that its emphasis on hope does not lull people
into a sense of complacency, Botswana subjected its
program logo and materials to pre-testing by experts at
the University of Botswana. Adopting a “train-the-trainer”
model, Botswana has trained 60 full-time treatment
educators to present information on hiv treatments in
workplaces, churches, schools, and other community
gathering places. 
In this hiv treatment education initiative, Botswana
balances the positive news about art with information
about the limitations of current drugs. Botswana’s
program, for example, strongly emphasizes that art is 
not a cure for hiv/aids. Educational
sessions inform participants of the
side effects of art and note that
people infected with the virus are
encouraged to stay off art until such
drugs are medically indicated. All
presentations and materials produced
in connection with Botswana’s treat-
ment literacy initiatives emphasize
condom use and provide instructions
on how to use condoms correctly. 
As art access expands, timely
information on the behavioral
impact of art will be critical to 
effective prevention planning.
Research will also be needed to 
identify effective prevention
messages and program models in 
an era of more widespread access 
to art.
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This poster from Botswana’s masa hiv
treatment program is part of a campaign to
educate the public about the benefits and
limitations of hiv therapy.
NOT
As fewer people become ill and fewer die,
aids may come to seem less threatening
and risk behavior could increase. 
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funding a 
comprehensive
response
Although funding for hiv/aids
programs has increased in recent
years, it remains far short of what 
is needed for an effective response
to the global epidemic. unaids
estimates that funding for hiv-
related interventions at the country
level totaled $4.7 billion in 2003 —
less than one-half of amounts
needed by 2005 ($10.5 billion) and
under one-third of what will be
required by 2007 ($15 billion).52
Separate estimates by who/unaids
project that $5.5 billion will be
needed over the 2004–2005 period
to ensure 3 million people on art in
high-priority countries. Funding for research into new
prevention technologies should also increase substantially
to $1 billion annually for hiv vaccines and $300 million
annually for microbicides by 2007. Resources should
also increase for research into other prevention tech-
niques such as female condoms, circumcision, treatment
of viral stds, and oral chemoprophylaxis.
As a result of under-financing, prevention programs
currently reach fewer than one in five of people at high
risk of infection, and only 7% of people in low- and
middle-income countries who need art have access to
the regimens. Only 5% of pregnant women received 
services in 2001 to prevent mother-to-child transmission;
12% of individuals who wanted to be tested for hiv had
access to testing and counseling services; and 19% of
injecting drug users could obtain harm reduction services.
Globally, fewer than one in four people worldwide had
access in 2001 to basic aids education, and only 42% of
people who wanted to use a condom during sex could
obtain one. 
The costs of integrating prevention into hiv treatment
settings may be relatively small. The cost of failing to
integrate prevention and treatment services, however, 
will be significant since the number of new infections
will continue to grow, with a resulting need to continually
expand hiv treatment services. Due to dramatic under-
funding of hiv/aids programs of all kinds, however, 
integrated programs will reach few who need them
unless the entire response to the epidemic is brought 
to scale. To capitalize on the momentous opportunity
afforded by art access to produce durable progress
against the epidemic, funding for both prevention and
treatment programs must simultaneously increase. 
Unfortunately, the experience in developed countries,
where art scale-up began in the mid-1990s, suggests
that commitment to prevention sometimes wanes when
new treatments emerge. In the U.S., for example, public
sector expenditures for hiv treatment and research are
substantially higher than those devoted to prevention
activities. In recent years, public spending on hiv preven-
tion has grown at a notably slower pace than other forms
of hiv-related programming (e.g., care and treatment,
housing, and research).53
In addition to inadequate funding, a major barrier 
to rapid expansion of prevention and hiv treatment
programs is the frequent lack of national capacity to
absorb substantial new funding. To make funding
increases meaningful, donors, technical agencies,
national governments, and other stakeholders must also
significantly strengthen efforts to expand sustainable
national capacity. 
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When art first emerged in the mid-1990s, wealthy coun-
tries rapidly brought treatment programs to scale, ensuring
universal access to these new therapies. art access, for
example, produced dramatic public health results. In the
U.S., hiv-related mortality declined by 66% between 1995
and 2002.54
As art programs were expanded in industrialized
countries, however, prevention messages often continued
to be the same ones used in the pre-art era. 
As art drew patients to health care settings, hiv
prevention interventions were not incorporated in clinical
practice. Surveys have repeatedly found that hiv health
care providers in the U.S. seldom inquire about sexual risk
behavior or provide related counseling.55
In the treatment era, risk behaviors have increased in
industrialized countries. Especially among men who have
sex with men (msm), substantial evidence has emerged of
an overall increase in risk behavior in recent years.56
Outbreaks of syphilis and gonorrhea among msm illustrate
the increased level of risk behavior in many industrialized
countries.57 Several studies have linked these increases in
risk behavior to the growing perception among many msm
that the advent of art has made hiv/aids less threat-
ening,58 particularly as hiv-related mortality has declined.
Recently, evidence indicates that this phenomenon is
beginning to affect the trajectory of the hiv/aids epidemic 
in some industrialized countries. 
In the United Kingdom, where studies have documented
recent increases in sexual risk behavior, nearly twice as
many people were diagnosed with hiv in 2002 as in 1998.
For the European Union as a whole, the
annual number of new hiv diagnoses
increased notably between 2000 and 
2002 among all major population groups
except injecting drug users, with especially
significant increases among heterosexuals
(excluding cases among immigrants 
from countries with generalized hiv/aids
epidemics).59 The rate of new hiv
diagnoses is also on the rise in Canada,
with notable increases among msm.60
In Australia, the annual number of new hiv
diagnoses increased by 23% between 1998
and 2002, with a growing share of new
diagnoses representing recent infection.61
Likewise, in the U.S., the overall
increase in risk behavior appears to have
overwhelmed the beneficial prevention effects of wide-
spread art utilization.62 In the 29 U.S. states that had hiv
infection reporting systems in place by 1999, the number
of hiv diagnoses among msm significantly increased
between 1999–2002.63 Analysis of available data has led
cdc to conclude that these trends in new diagnoses likely
reflect an actual increase in new infections (as opposed,
for example, to increased utilization of testing services
and knowledge of hiv status).64
In response to these emerging trends, public health
agencies in industrialized countries are now actively
working to update prevention strategies to ensure their
effectiveness in the treatment era. The U.S. Department 
of Health and Human Services recently issued recommen-
dations for incorporating hiv prevention services in hiv-
related medical care settings.65 In 2003, cdc announced 
a new national hiv prevention strategy with an emphasis
on prevention/treatment integration; key components
include promoting hiv testing and counseling, imple-
menting prevention programs specifically targeted to
people living with hiv, and strengthening national efforts
to prevent mother-to-child transmission.
As hiv treatment expands in developing countries, 
the global community should learn from the experience 
of industrialized countries. As art access is expanded,
prevention services must be brought to scale as well.
Prevention programs should be integrated in all health
care settings, and prevention strategies should be revised
to meet the differing needs of hiv-positive and hiv-
negative people.
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industrialized countries: a cautionary tale
o capture the many opportunities to expand
hiv prevention as access to art increases and
significantly reduce hiv incidence over the coming
years, the Working Group makes the following
recommendations and urges their rapid implementation: 
1. INTEGRATE 
HIV PREVENTION AND
TREATMENT
Access to voluntary counseling and testing
programs should be significantly expanded.
t In Areas Where art Access Exists, Voluntary hiv
Counseling and Testing Should Be Universally Offered 
in Diverse Health Care Settings. Where art access is
available, providers should always offer voluntary hiv
counseling and testing in a broad range of health care
settings, including hospitals, pmtct programs, family
planning and reproductive health clinics, std and tb
clinics, blood donation sites, and in mobile health
programs in rural areas.66 Testing should in all cases
remain confidential and voluntary, and clients should
have the right to opt out of testing. All blood donations
should be screened for hiv and other bloodborne
diseases.
t Funding Should Increase for vct. The number of vct
centers should significantly increase, and staffing for
existing centers should grow. Testing services should be
offered free of charge, as studies suggest that service fees
often discourage individuals from voluntarily learning
their hiv status.67
t The Importance of Knowing hiv Status Should be
Effectively Marketed. State-of-the-art social marketing
techniques should be used to promote knowledge of 
hiv status and address attitudinal barriers to voluntary
testing. Social marketing has effectively been employed
to promote condom use,68 and early experience in devel-
oping countries suggests that social marketing may be
successful, as well, in promoting use of hiv testing and
counseling services.69
t Expand Use of Rapid Testing Technologies. Rapid
testing technologies are ideal for widespread use in
resource-limited settings, as they are relatively inexpen-
sive,70 are extremely accurate,71 and do not require highly
trained laboratory technicians.72 Rapid testing enables
individuals to receive test results in a matter of minutes
rather than waiting for hours or even days. Rapid testing
also permits vct to be delivered in a wide range of 
non-clinical sites, including churches and mosques,
workplaces and community centers. 
t Expand Access to Post-Test Services. vct sites, 
community groups, and hiv clinics should offer a variety
of post-test services. Post-test services can provide vital
hiv prevention information to people who have just
tested positive, help hiv-positive individuals cope with
their diagnosis, link individuals to art, help individuals
prevent transmission to their partners, and provide
avenues for people living with hiv/aids to develop
communications and advocacy networks. 
All health care settings, including hiv
treatment sites, should deliver hiv
prevention services.
t Deliver hiv Prevention Services in hiv/aids Clinical
Settings. Training in delivering brief hiv prevention 
interventions should be included in art-related training
protocols. Both clinical and non-clinical staff in health
care settings should receive training, as all will need to
contribute to the delivery of hiv prevention messages.
Staff should also receive training in proper infection
control procedures. Clinic appointments should be struc-
tured to facilitate the delivery of prevention interventions.
Male and female condoms should be readily available in
all health care settings. As new technologies emerge, such
as vaccines or microbicides, health systems will need to
adapt to quickly integrate these new prevention tools.
RECOMMENDATIONS
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t Integrate Prevention and Adherence Support Programs.
Clinic-based adherence counselors, leaders of patient support
groups, and other adherence workers should receive hiv
prevention training. Written informational materials on
adherence should be supplemented with information on
risk reduction targeted to the needs of people with hiv/aids.
t Emphasize Prevention and art in Prenatal Settings
and in Programs to Prevent Mother-to-Child Transmis-
sion (pmtct). Early experience in the pmtct field
confirms that access to art can facilitate hiv prevention.
In the six Elizabeth Glaser Pediatric aids Foundation
sites that have initiated art programs through mtct-Plus,
demand for testing and counseling has significantly
increased, and community attitudes toward hiv/aids
have rapidly begun to change.
t Provide Prevention and hiv Treatment in std and tb
Clinics. Training should be provided to personnel in 
std and tb clinics to enable them to deliver brief hiv
prevention interventions. In addition, training should
equip personnel in std and tb clinics to make timely
referrals for hiv prevention services and hiv/aids
clinical care. 
t Integrate Prevention in Family Planning and 
Reproductive Health Services. Because family planning
and reproductive health services function as a key entry
point for hiv-infected and at-risk women, hiv prevention
training should be provided to reproductive health
personnel. 
t Particular Efforts for Women. Issues affecting hiv
treatment and prevention access for women should be
comprehensively addressed, ranging from cost of hiv
treatment, transportation, and child care, to sufficient
numbers of women health workers, and guarantees of
privacy and confidentiality. art and prevention programs
should provide women with counseling, referrals, and
follow-up about the risk of abandonment or violence 
after disclosing their hiv status, including links to safe
shelters for women.
art should be promoted and/or delivered 
in the context of prevention services.
t Promote art Through Prevention Programs. Prevention
outreach and educational efforts should promote 
knowledge of hiv status, educate people at risk about
hiv/aids treatments, and facilitate linkage to care and
treatment services. 
t Integrate Prevention and hiv Treatment in Harm
Reduction Settings. hiv/aids prevention and medical 
services — including access to art, screening and 
treatment for tb and stds, prevention interventions, 
and drug treatment — should be integrated into harm
reduction programs for injecting drug users. Funding for
harm reduction programs should significantly increase,
and laws should be revised, where needed, to legalize
methadone maintenance and needle syringe programming
and address other official impediments to harm reduction. 
Donors and national programs should 
prioritize integration of prevention and 
art services.
t All art Initiatives Should Establish Policies to Promote
Integrated Services. In cooperation with national govern-
ments, donors should prioritize community-based 
strategies for the delivery of integrated art and prevention
programs. The Global Fund and the World Bank should
prioritize funding for country proposals on hiv/aids that
integrate prevention and art. who should ensure that 3 
by 5 Initiative staff receive training on hiv prevention as
part of training and technical assistance activities. In their
assistance to countries in developing proposals for the
Global Fund, unaids and who should emphasize the
importance of integrating prevention services in hiv
treatment settings. All bilateral funding sources should
promote integration of prevention services in art settings;
for example, the U.S. government should ensure that all
programs funded through the President’s Emergency 
Plan for aids Relief (pepfar) integrate science-based hiv
prevention in the delivery of hiv treatment. Countries
should revise their aids strategic plans to prioritize 
integration of hiv prevention in art settings. 
t Donors Should Require That Reports of Country 
Activities Specify How Prevention and hiv Treatment are
Being Integrated. Bilateral programs such as the U.S.
pepfar initiative should require programs that receive
funding to provide documentation on provision of
prevention services in treatment settings and on clinical
linkages and coordination with other prevention services. 
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Research efforts should be strengthened 
and expanded to help inform the scaling-up
of an integrated response to hiv/aids.
t Support Research on Integration. Donors and research
agencies should collaborate on research to identify the
most effective strategies to integrate prevention and art
programs, and to promote testing and counseling services.
t Research Results Must Be Disseminated Rapidly. who
and unaids should develop communications mechanisms
to facilitate rapid delivery of research findings to the field.
Bilateral and international technical agencies should be
prepared to assist national governments in integrating new
research findings into national policies and programs.
2. DELIVER PREVENTION
FOR HIV-POSITIVE PEOPLE
t New Prevention Programs Tailored to the Needs 
of People Living with hiv Should Be Developed and
Implemented. “Prevention for positives” should include
counseling regarding personal disclosure of hiv status,
information on the ability of individuals to transmit 
hiv even while on art, assistance in identifying and
addressing impediments to safer behavior, and promo-
tion of accessible std screening. Programs should
acknowledge the natural desire of many people with hiv
to be sexually active, and provide individually tailored
support to facilitate safer sexual choices. 
t All Countries Should Include the Delivery of 
Prevention Services for People with hiv in their National
aids Plans. Programs to address the unique hiv preven-
tion needs of people living with hiv should be an integral
part of each country’s broader strategy to fight hiv/aids.
t Prevention Services for People Living with hiv Must 
Be Supported by Strengthened and Sustained Efforts to
Combat hiv-related Stigma and Discrimination. In many
countries, stigma against people living with hiv remains a
major deterrent to expanded voluntary hiv counseling and
testing and provision of art and prevention services. 
Anti-stigma campaigns, anti-discrimination protections,
and political leadership are all necessary to combat 
negative social attitudes. 
t Involve Organizations of People with hiv. People
living with hiv/aids (plwha) remain a major under-
utilized resource in the fight against the global epidemic.
Donors should direct significant financial support to
plwha organizations, and these organizations should 
be actively engaged in the delivery of hiv prevention 
services to hiv-positive people.
t Research Should Be Urgently Undertaken to Identify
Optimal Messages and Strategies for Reaching hiv-
Positive People. Best practices must be rapidly and widely
disseminated.
3. ADAPT PREVENTION 
FOR HIV-NEGATIVE PEOPLE
t Prevention Strategies for hiv-Negative and Untested
People Should Be Revised to Emphasize the Continuing
Importance of Risk Reduction. Without further stigma-
tizing people living with hiv, prevention programs will
need to persuade individuals at risk that hiv/aids remains
a serious, incurable disease that should be avoided. 
t Community-Based Prevention and Education
Programs Must Help People — Both Infected and 
Uninfected — to Understand the Benefits and Limitations
of art. While promoting the benefits of art, programs
should emphasize that art is not a cure and that patients
undergoing treatment could spread the virus to their
partners.
t Capacity to Undertake Behavioral Surveillance and
Sentinel Surveillance Must Be Significantly Expanded 
to Monitor the Behavioral Impact of art. Surveys should
be undertaken to assess any behavioral impact of art.
Special studies should be undertaken to monitor new hiv
infections in the treatment era. In addition, aggregate
information from routine voluntary and confidential hiv
testing should be collected and analyzed on an ongoing
basis from key settings, such as prenatal clinics. 
t Research Should Identify Optimal Prevention
Messages and Strategies in the Treatment Era. The global
community must prioritize research to identify effective
messages in this new era and ensure the swift dissemina-
tion of best practices to the field.
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4. FUND A COMPREHENSIVE
RESPONSE 
t Funding for hiv Prevention and Treatment Programs
Should Grow to at Least $10.5 Billion in 2005 and $15
Billion in 2007. Even though existing prevention strate-
gies could, if adequately funded, prevent 63% of all new
infections projected during this decade,73 hiv prevention
has yet to attract sufficient donor support. With minimal
art coverage worldwide, funding for hiv-related treat-
ment is even more inadequate. unaids estimates that
funding for all hiv-related interventions at country-level
totaled $4.7 billion in 2003 — less than one-half of
amounts needed by 2005 ($10.5 billion) and under one-
third of what will be required by 2007 ($15 billion). 
t Funding Initiatives for Prevention and hiv Treatment
Must Emphasize Both Short- and Long-term Strategies 
to Build Sustainable Capacity in Countries. Short-term
strategies may include intensive training initiatives,
preceptorship programs, and virtual networks for consul-
tation and learning. Longer-term strategies include
substantial investments in medical and other education,
health care infrastructure, as well as comprehensive
efforts to strengthen key national sectors. 
t Support for hiv Prevention Research Should Be
Substantially Increased. Annual funding for hiv vaccine
research should double from approximately $520 million
to $570 million today to at least $1 billion in 2007. Annual
funding for microbicide research should increase from less
than $150 million today to $300 million in 2007. Funding
for research into other prevention technologies — such as
female condoms, diaphragms, circumcision, treatment of
viral stds, and oral chemoprophylaxis — should increase
substantially. In addition, because the infrastructure needs
for conducting hiv prevention research in developing
countries are similar to the infrastructure needed for
ongoing primary prevention and art efforts, opportunities
to participate in clinical trials of new prevention technolo-
gies should be linked with hiv testing, prevention, and
treatment services. 
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